Idiopathic pulmonary fibrosis: is it a familial disease?

被引:18
作者
Allam, J. Shirine
Limper, Andrew H.
机构
[1] Mayo Clin, Coll Med, Dept Internal Med, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA
关键词
familial interstitial pulmonary fibrosis; genetics; interstitial pulmonary fibrosis; surfactant proteins;
D O I
10.1097/01.mcp.0000239546.24831.61
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Idiopathic pulmonary fibrosis is a progressively fatal interstitial lung disease associated with pathological findings of usual interstitial, pneumonia. Its pathognesis is unknown, and there are no proven effective therapies Familial cases account for 0.5-2% of idiopathic pulmonary fibrosis. Familial idiopathic pulmonary fibrosis occurs as an autosomal dominant disorder with variable penetrance. The clinical characteristics of familial idiopathic pulmonary fibrosis are indistinguishable from sporadic idiopathic pulmonary fibrosis. These marked similarities support the hypothesis there may, in part, be a genetic basis for idiopathic pulmonary fibrosis. Recent findings Many investigations have evaluated genetic polymorphisms and idiopathic pulmonar fibrosis. Candidate genes include and surfactant protein genes. To date, no gene has been consistently identified to be-associated with idiopathic pulmonary fibrosis. Recent studies in familial, idiopathic pulmonary fibrosis have demonstrated a strong association with surfactant protein C gene mutations in one large kindred. Summary The pathogenesis of both idiopathic pulmonary fibrbsis and familial idiopathic pulmonary fibrosis remains unclear. A consistent genetic basis has not yet been demonstrated in all cases. Other factors, including variable gene expression, co-carriage of other modifying genes and environmental stimuli, particularly cigarette smoke, significantly contribute to disease expression.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 40 条
[1]   Surfactant protein deficiency in familial interstitial lung disease [J].
Amin, RS ;
Wert, SE ;
Baughman, RP ;
Tomashefski, JF ;
Nogee, LM ;
Brody, AS ;
Hull, WM ;
Whitsett, JA .
JOURNAL OF PEDIATRICS, 2001, 139 (01) :85-92
[2]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[3]   FAMILIAL IDIOPATHIC PULMONARY FIBROSIS - EVIDENCE OF LUNG INFLAMMATION IN UNAFFECTED FAMILY MEMBERS [J].
BITTERMAN, PB ;
RENNARD, SI ;
KEOGH, BA ;
WEWERS, MD ;
ADELBERG, S ;
CRYSTAL, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (21) :1343-1347
[4]   TRANSFORMING GROWTH FACTOR-BETA-1 IS PRESENT AT SITES OF EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN PULMONARY FIBROSIS [J].
BROEKELMANN, TJ ;
LIMPER, AH ;
COLBY, TV ;
MCDONALD, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6642-6646
[5]  
Freeburn RW, 2001, EUR CYTOKINE NETW, V12, P33
[6]  
FULMER JD, 1978, AM REV RESPIR DIS, V118, P141
[7]  
GEDDES DM, 1977, LANCET, V2, P1049
[8]   Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland [J].
Hodgson, U ;
Laitinen, T ;
Tukiainen, P .
THORAX, 2002, 57 (04) :338-342
[9]   Role of interleukin-10 in the lung response to silica in mice [J].
Huaux, F ;
Louahed, J ;
Hudspith, B ;
Meredith, C ;
Delos, M ;
Renauld, JC ;
Lison, D .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (01) :51-59
[10]   Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis:: a case-control study [J].
Hubbard, R ;
Baoku, Y ;
Kalsheker, N ;
Britton, J ;
Johnston, I .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (12) :2881-2883